Key result
Oseltamivir therapy, added to methylprednisolone and colchicine, led to progressive clinical improvement and complete resolution of life-threatening pericardial effusion caused by Influenza B virus.
Why the study?
Influenza B virus infection complicated by pericarditis without myocardial involvement had never been reported.
Case Report (n=1)
No
This is the first reported case of life-threatening pericarditis without myocardial involvement caused by influenza B virus, successfully treated with oseltamivir.
Alerts clinicians to influenza B as a potential isolated pericarditis cause; leaves open whether routine viral testing should be adopted.
BACKGROUND: Acute pericarditis may occur frequently after viral infections. To our knowledge, influenza B virus infection complicated by pericarditis without myocardial involvement has never been reported. We report the first case of life-threatening pericarditis caused by influenza B virus infection. CASE PRESENTATION: A 48-years-old woman with trisomy 21 and ostium primum atrial septal defect was transferred from Cardiology to our Internal Medicine Department for severe pericardial effusion unresponsive to ibuprofen and colchicine. Based on the recent patient history of flu-like syndrome, and presence of pleuro-pericardial effusion, a viral etiology was suspected. Laboratory evaluation and molecular assay of tracheal aspirate identified influenza B virus. Therefore, the ongoing metilprednisolone and colchicine therapy was implemented with oseltamivir with progressive patient improvement and no evidence of pericardial effusion recurrence during follow-up. CONCLUSIONS: Especially in autumn and winter periods, clinicians should include Influenza B virus infection on differential diagnosis of pericarditis with large pericardial effusion.
No takes yet. Share an insight, caveat, or question.
Spoto et al. (2019) conducted a case report in Influenza B virus infection complicated by life-threatening pericarditis (n=1). Oseltamivir was evaluated on Clinical and echocardiographic improvement (resolution of pericardial effusion). Oseltamivir therapy, added to methylprednisolone and colchicine, led to progressive clinical improvement and complete resolution of life-threatening pericardial effusion caused by Influenza B virus.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: